ACL australian clinical labs limited

News: ACL Australian Clinical Labs Says HY Total Revenue From Ordinary Activities Down 33.03% To...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :

    • HY TOTAL REVENUE FROM ORDINARY ACTIVITIES DOWN 33.03% TO A$360.3M
    • HY PROFIT ATTRIBUTABLE DOWN 80.48% TO A$25.4M
    • DECLARED INTERIM DIVIDEND OF 7.00 AU CENTS PER SHARE
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.60
Change
-0.030(1.14%)
Mkt cap ! $510.6M
Open High Low Value Volume
$2.64 $2.65 $2.59 $901.1K 345.8K

Buyers (Bids)

No. Vol. Price($)
3 18300 $2.60
 

Sellers (Offers)

Price($) Vol. No.
$2.62 2000 1
View Market Depth
Last trade - 16.10pm 05/09/2025 (20 minute delay) ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.